COVID-19 Vaccine Hesitancy in 53 Developing Countries
No hay miniatura disponible
Fecha
Título de la revista
ISSN de la revista
Título del volumen
Editor
World Bank, Washington, DC
Resumen
Descripción
This paper presents new evidence on
the levels and trends of vaccine hesitancy in developing
countries based on harmonized high-frequency phone surveys
from more than 120,000 respondents in 53 low- and
middle-income countries. These countries represent a
combined 30 percent of the population of low- and
middle-income countries. On average across countries, one in
five adults is hesitant about the COVID-19 vaccine, with the
most cited reasons for hesitancy being concerns about the
safety of the vaccine, followed by concerns about its
efficacy. Between late 2020 and the first half of 2021,
there tended to be little change in levels of hesitancy
except in Iraq, Malawi, and Uzbekistan, where hesitancy
increased. COVID-19 vaccine hesitancy is higher among
female, young, less educated, and rural respondents, after
controlling for selected observable characteristics. Country
estimates of vaccine hesitancy from the high-frequency phone
surveys are correlated with but lower than those from
earlier studies, which often relied on less representative
survey samples. The results suggest that vaccine hesitancy
in developing countries, while less prevalent than
previously thought, will be an important and enduring
obstacle to recovery from the pandemic.
Palabras clave
VACCINE HESITANCY, COVID-19 VACCINE, HIGH FREQUENCY PHONE SURVEY DATA, VACCINATION RATES IN DEVELOPING COUNTRIES, VACCINE SAFETY, VACCINE EFFICACY
